tirzepatide and antidepressants 349 Hotcakes: for weight loss, Personalized Antidepressants, Seasonal Edema, Nirmatrelvir for low-risk COVID-19 A recent post hoc analysis

Semaglutide is a GLP-1 receptor agonist that helps regulate appetite and improve insulin sensitivity, leading to effective weight loss and better blood sugar control

PMID 28301903

Their weight loss programs are FDA-approved and, when paired with a healthy diet and exercise, lead to significant and long-term results

Presented for research literature review only Dogliotti L et al

The FDA has issued public warnings about dosing errors and adverse events involving compounded semaglutide and tirzepatide - with more than 1,700 adverse events linked to compounded semaglutide and tirzepatide combined as of May 21, 2026, according to FDA's published adverse event data